Paricalcitol and Endothelial Function in Chronic Kidney Disease Patients (the PENNY Study)

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2011
The primary aim of this study was to test the hypothesis that Paricalcitol, an active form of vitamin D, improved endothelial function in stage 3-4 chronic kidney disease (CKD) patients. A secondary aim of this trial was to study the relationship between endothelial function and plasma/serum and genetic biomarkers of bone mineral disorders in CKD (BMD-CKD) and renin angiotensin-aldosteron system (RAS) (angiotensin II and plasma renin activity).
Epistemonikos ID: 1febc6fedeb220f62928e7afed956b6dc791154d
First added on: May 11, 2024